• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Coeptis Pharma Enters into Agreement to Acquire Elto Pharma firstwordpharma
    November 29, 2018
    Elto Phama is developing eltoprazine, a serotonergic agonist in Phase 2b development for the treatment of Parkinson's disease levodopa-induced dyskinesias (Parkinson's LID). Elto Pharma is a joint venture between Amarantus Bioscience Holdings, Inc. (OTCPK

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service